The MyTIME clinical trial

  • Zoe Bradfield (Creator)
  • Scott White (Contributor)
  • Mary Sharp (Contributor)
  • Jeff Keelan (Contributor)
  • Monique Rose (Contributor)
  • Jane Warland (Contributor)
  • Lesley Kuliukas (Contributor)
  • Miranda Davies-Tuck (Contributor)
  • Emily Callander (Contributor)
  • Kylie Ekin (Contributor)
  • Clare Ladyman (Contributor)
  • Dorota Doherty (Contributor)

Dataset

Description

HeSANDA 1.0.0
To study is a double-blind, randomised, placebo-controlled trial of daily oral melatonin administration from 39 weeks' gestation in nulliparous pregnant women to reduce induction of labour rates. Induction of labour will be the primary endpoint of the study.
Date made available2024
PublisherCurtin University
Geographical coverageAustralia

Cite this